Diphencyprone

DB12173InvestigationalSmall molecule

Diphencyprone has been used in trials studying the treatment and basic science of Melanoma, Ultraviolet Rays, Immunosuppression, Neoplasm Metastasis, and Hypersensitivity, Delayed, among others.

Chemical structure of Diphencyprone
Formula / weight
C15H10O · 206.244 g/mol (avg)
Also known as
Diphenylcyclopropenone

Resolves to

Compound
UNIII7G14NW5ECCAS886-38-4ChEMBLCHEMBL1373467ChEBI53074PubChem65057
Structure
InChIKeyHCIBTBXNLVOFER-UHFFFAOYSA-NSMILESO=C1C(=C1C1=CC=CC=C1)C1=CC=CC=C1

What you can answer from here — as of April 23, 2025

8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Diphencyprone, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In